Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
Chiodini et al., Frontiers in Public Health, doi:10.3389/fpubh.2021.736665
Chiodini et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Frontiers in Public Health, doi:10.3389/fpubh.2021.736665
Dec 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Meta analysis concluding that "patients with low vitamin D levels present an increased risk of ARDS requiring admission to intensive care unit (ICU) or mortality due to SARS-CoV-2 infection and a higher susceptibility to SARS-CoV-2 infection and related hospitalization".
Currently there are 107 vitamin D studies and meta analysis shows:
OutcomeImprovement
Mortality36% lower [28‑44%]
Ventilation26% lower [-2‑46%]
ICU admission50% lower [33‑62%]
Hospitalization20% lower [8‑31%]
Cases15% fewer [6‑23%]
Chiodini et al., 22 Dec 2021, peer-reviewed, 13 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: SYSTEMATIC REVIEW published: 22 December 2021 doi: 10.3389/fpubh.2021.736665 Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes Iacopo Chiodini 1,2*† , Davide Gatti 3† , Davide Soranna 4 , Daniela Merlotti 5 , Christian Mingiano 5 , Angelo Fassio 3 , Giovanni Adami 3 , Alberto Falchetti 6 , Cristina Eller-Vainicher 7 , Maurizio Rossini 3 , Luca Persani 1,2 , Antonella Zambon 4,8 and Luigi Gennari 5 1 Department of Endocrine and Metabolic Diseases, Istituto di Ricovero e Cura a Caratttere Scientifico (IRCCS), Istituto Auxologico Italiano, Milan, Italy, 2 Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy, 3 Rheumatology Unit, University of Verona, Verona, Italy, 4 Biostatistic Unit, Istituto di Ricovero e Cura a Caratttere Scientifico (IRCCS), Istituto Auxologico Italiano, Milan, Italy, 5 Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy, 6 Unit of Rehabilitation Medicine, San Giuseppe Hospital, Istituto di Ricovero e Cura a Caratttere Scientifico (IRCCS), Istituto Auxologico Italiano, Piancavallo, Italy, 7 Unit of Endocrinology, Fondazione Istituto di Ricovero e Cura a Caratttere Scientifico (IRCCS) Cà Granda, Milan, Italy, 8 Department of Statistics and Quantitative Methods, Università di Milano-Bicocca, Milan, Italy Edited by: Yoav Keynan, University of Manitoba, Canada Reviewed by: Naveen Kumar Devanga Ragupathi, The University of Sheffield, United Kingdom William B. Grant, Sunlight Nutrition and Health Research Center, United States *Correspondence: Iacopo Chiodini iacopo.chiodini@unimi.it † These authors have contributed equally to this work Specialty section: This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Public Health Received: 27 July 2021 Accepted: 11 November 2021 Published: 22 December 2021 Citation: Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, Adami G, Falchetti A, Eller-Vainicher C, Rossini M, Persani L, Zambon A and Gennari L (2021) Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front. Public Health 9:736665. doi: 10.3389/fpubh.2021.736665 Background: Several studies suggest an association between serum 25-hydroxyvitamin D (25OHD) and the outcomes of Severe Acute Respiratory Syndrome Corona-Virus-2 (SARS-CoV-2) infection, in particular Coronavirus Disease-2019 (COVID-19) related severity and mortality. The aim of the present meta-analysis was to investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints). Methods: A search in PubMed, ScienceDirect, Web of Science, Google Scholar, Scopus, and preprints repositories was performed until March 31th 2021 to identify all original observational studies reporting association measures, or enough data to calculate them, between Vitamin D status (insufficiency <75, deficiency <50, or severe deficiency <25 nmol/L) and risk of SARS-CoV-2 infection, COVID-19 hospitalization, ICU admission, or death during COVID-19 hospitalization. Findings: Fifty-four studies (49 as fully-printed and 5 as pre-print publications) were included for a total of 1,403,715 individuals. The association between vitamin D status and SARS-CoV2 infection, COVID-19..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit